" /> Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207 - CISMeF





Preferred Label : Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207;

NCIt synonyms : Recombinant Saccharomyces Cerevisia-CEA 610D Expressing Vaccine GI-6207;

NCIt related terms : GI-6207;

NCIt definition : A whole, heat-killed, recombinant Saccharomyces cerevisiae yeast-based vaccine genetically altered to express the carcinoembryonic antigen (CEA) peptide 610D with potential immunostimulating and antineoplastic activities. Upon administration, recombinant Saccharomyces cerevisia-CEA(610D) vaccine GI-6207 may stimulate a host cytotoxic T-lymphocyte (CTL) response against CEA-expressing tumor cells, which may result in tumor cell lysis. CEA, a tumor associated antigen, is overexpressed on a wide variety of human cancer cells including colorectal, gastric, lung, breast and pancreatic cancer cells. CEA 610D encodes for 9 amino acids (605-613) in which aspartate is substituted for asparagine at position 610 (610D) in order to strengthen the induction of the CTL response against CEA-expressing tumor cells.;

UNII : FIJ3OLQ3N8;

Molecule name : GI-6207;

Details


You can consult :


Nous contacter.
10/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.